Skip to main content

Remote Job Finders (RJF)

FDA Formally Rejects Regeneron’s Eylea HD Over Manufacturing Issues

Despite the rejection, analysts saw Regeneron’s use of an alternate filler for Eylea HD as a positive development, with BMO Capital Markets noting that this could signal the end of manufacturing troubles for the franchise.
Scroll to top